The FDA lists BPC-157 as a Category 2 bulk drug substance, which limits where it can be legally compounded
PubMed Duzel, A., Vlainic, J., Antunovic, M., Malekinusic, D., Vrdoljak, B., Samara, M., Gojkovic, S., Krezic, I., Vidovic, T., Bilic, Z., Sjekavica, I., Djuzel, A.R., Knezevic, M., Sever, A.Z., Lojo, N., Kokot, A., Sever, M., Drmic, D., Seiwerth, S., Sikiric, P
Recent advancements in peptide engineering have even explored the creation of tandem thymosin beta-4 (tTB4) moleculesfusing two monomers to create dual G-actin binding domainswhich have shown superior bioactivity in treating severe corneal wounds, highlighting the immense pharmacological potential of this specific amino acid sequence
doi: 10.1016/j.jhep.2012.10.005 55 HiseA
References
Focused on the Plus one golfer, Founder Katre Klow created a refreshing new look to the golf stroke counter bracelet